Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 5
Submit an article Journal homepage
2,451
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis

Diana GrozaInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaORCID Iconhttp://orcid.org/0000-0001-6499-3759View further author information
ORCID Icon,
Sebastian GehrigLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Pavol KudelaBIRD-C GmbH & CoKG, Vienna, AustriaView further author information
,
Martin HolcmannInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Christine PirkerInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Carina DinhofInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Hemma H. SchuefflInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaView further author information
,
Marek SramkoBIRD-C GmbH & CoKG, Vienna, AustriaORCID Iconhttp://orcid.org/0000-0003-1140-6674View further author information
ORCID Icon,
Julia HoebartLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaORCID Iconhttp://orcid.org/0000-0003-1750-1680View further author information
ORCID Icon,
Fatih AliogluLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Michael GruschInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaORCID Iconhttp://orcid.org/0000-0001-5486-9340View further author information
ORCID Icon,
Manfred OgrisLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Werner LubitzBIRD-C GmbH & CoKG, Vienna, AustriaView further author information
,
Bernhard K. KepplerInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaView further author information
,
Irena Pashkunova-MarticInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Christian R. KowolInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaView further author information
,
Maria SibiliaInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Walter BergerInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaCorrespondence[email protected]
View further author information
&
Petra HeffeterInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaCorrespondence[email protected]
View further author information
 show all
Article: e1424676 | Received 04 Dec 2017, Accepted 29 Dec 2017, Published online: 16 Feb 2018

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Siamak Alizadeh, Abolghasem Esmaeili, Abolfazl Barzegari, Mohammad A. Rafi & Yadollah Omidi. (2020) Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours. Journal of Drug Targeting 28:7-8, pages 700-713.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now

Articles from other publishers (29)

Rui Zong, Hainan Ruan, Chanmin Liu, Shaohua Fan & Jun Li. (2023) Bacteria and Bacterial Components as Natural Bio-Nanocarriers for Drug and Gene Delivery Systems in Cancer Therapy. Pharmaceutics 15:10, pages 2490.
Crossref
Nessrin Saleh, Hoda E. Mahmoud, Hoda Eltaher, Maged Helmy, Labiba El-Khordagui & Ahmed A. Hussein. (2022) Prodigiosin-Functionalized Probiotic Ghosts as a Bioinspired Combination Against Colorectal Cancer Cells. Probiotics and Antimicrobial Proteins 15:5, pages 1271-1286.
Crossref
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, Sevda Jafari & Soheila Montazersaheb. (2023) Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds. Cancer Cell International 23:1.
Crossref
Xianghe Jiang, Lili Wu, Mengya Zhang, Tinglin Zhang, Cuimin Chen, Yan Wu, Chuan Yin & Jie Gao. (2023) Biomembrane nanostructures: Multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery. Journal of Controlled Release 361, pages 510-533.
Crossref
Min Zhou, Yucheng Tang, Wenjie Xu, Xinyan Hao, Yongjiang Li, Si Huang, Daxiong Xiang & Junyong Wu. (2023) Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies. Frontiers in Immunology 14.
Crossref
Jirakrit Saetang, Phutthipong Sukkapat, Ajay Mittal, Jakrawadee Julamanee, Wannakorn Khopanlert, Kajornkiat Maneechai, Rasool Abdul Nazeer, Surasak Sangkhathat & Soottawat Benjakul. (2023) Proteome Analysis of the Antiproliferative Activity of the Novel Chitooligosaccharide–Gallic Acid Conjugate against the SW620 Colon Cancer Cell Line. Biomedicines 11:6, pages 1683.
Crossref
Paul Strasser, Bianca Montsch, Silvia Weiss, Haider Sami, Christoph Kugler, Sonja Hager, Hemma Schueffl, Robert Mader, Oliver Brüggemann, Christian R. Kowol, Manfred Ogris, Petra Heffeter & Ian Teasdale. (2023) Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo. Small 19:22.
Crossref
Chenchao Feng, Peng Tan, Guangjun Nie & Motao Zhu. (2023) Biomimetic and bioinspired nano‐platforms for cancer vaccine development. Exploration 3:3.
Crossref
Jiaqi Zhai, Xi Gu, Yang Liu, Yueting Hu, Yi Jiang & Zhenyong Zhang. (2023) Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. Frontiers in Pharmacology 14.
Crossref
Yixin Wang, Zhaoting Li, Fanyi Mo, Ting-Jing Chen-Mayfield, Aryan Saini, Afton Martin LaMere & Quanyin Hu. (2023) Chemically engineering cells for precision medicine. Chemical Society Reviews 52:3, pages 1068-1102.
Crossref
Haojie Chen, Pengyu Lei, Hao Ji, Qinsi Yang, Bo Peng, Jiahui Ma, Yimeng Fang, Linkai Qu, Hua Li, Wei Wu, Libo Jin & Da Sun. (2023) Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies. Materials Today Bio 18, pages 100543.
Crossref
Atieh Yaghoubi, Kiarash Ghazvini, Seyed Mahdi Hasanian, Amir Avan, Saman Soleimanpour & Majid Khazaei. (2022) Bacterial Peptides and Bacteriocins as a Promising Therapy for Solid Tumor. Current Pharmaceutical Design 28:38, pages 3105-3113.
Crossref
Ya-Jia Xie, Min Huang, Dan Li, Jin-Cai Hou, Hai-Hai Liang, Ali Adnan Nasim, Ju-Min Huang, Chun Xie, Elaine Lai-Han Leung & Xing-Xing Fan. (2022) Bacteria-based nanodrug for anticancer therapy. Pharmacological Research 182, pages 106282.
Crossref
Manisha Pandey, Hira Choudhury, Prathiba A/P Vijayagomaran, Pauline Ng Poh Lian, Tan Jing Ning, Ng Zing Wai, Ng Xian-Zhuang, Chong Le Er, Nur Suraiza Nabila Rahmah, Nur Dayana Binti Kamaruzzaman, Jayashree Mayuren, Mayuren Candasamy, Bapi Gorain, Pooja A. Chawla & Mohd Cairul Iqbal Mohd Amin. (2022) Recent Update on Bacteria as a Delivery Carrier in Cancer Therapy: From Evil to Allies. Pharmaceutical Research 39:6, pages 1115-1134.
Crossref
Yuzhu Yao, Jianye Li, Puze Li, Dongdong Wang, Wei Bao, Yi Xiao, Xue Chen, Shuaicheng He, Jun Hu & Xiangliang Yang. (2021) Bacterially Synthesized Tellurium Nanorods for Elimination of Advanced Malignant Tumor by Photothermal Immunotherapy. Small 18:8.
Crossref
Jiayao Ma, Lingjuan Huang, Die Hu, Shan Zeng, Ying Han & Hong Shen. (2021) The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Magdalena Billerhart, Monika Schönhofer, Hemma Schueffl, Wolfram Polzer, Julia Pichler, Simon Decker, Alexander Taschauer, Julia Maier, Martina Anton, Sebastian Eckmann, Manuel Blaschek, Petra Heffeter, Haider Sami & Manfred Ogris. (2021) CD47-targeted cancer immunogene therapy: Secreted SIRPα-Fc fusion protein eradicates tumors by macrophage and NK cell activation. Molecular Therapy - Oncolytics 23, pages 192-204.
Crossref
Mounir M. Salem-Bekhit, Abdullah M. E. Youssof, Fars K. Alanazi, Fadilah Sfouq Aleanizy, Alsuwyeh Abdulaziz, Ehab I. Taha & Amro Abd Al Fattah Amara. (2021) Bacteria from Infectious Particles to Cell Based Anticancer Targeted Drug Delivery Systems. Pharmaceutics 13:12, pages 1984.
Crossref
Haojie Chen, Hao Ji, Xiangjun Kong, Pengyu Lei, Qinsi Yang, Wei Wu, Libo Jin & Da Sun. (2021) Bacterial Ghosts-Based Vaccine and Drug Delivery Systems. Pharmaceutics 13:11, pages 1892.
Crossref
Eskandar Moghimipour, Samaneh Abedishirehjin, Maryam Abedini Baghbadorani & Somayeh Handali. (2021) Bacteria and Archaea: A new era of cancer therapy. Journal of Controlled Release 338, pages 1-7.
Crossref
Wenjing Zai, Lin Kang, Tiejun Dong, Haoran Wang, Lining Yin, Shaoju Gan, Wenjia Lai, Yibing Ding, Yiqiao Hu & Jinhui Wu. (2021) E. coli Membrane Vesicles as a Catalase Carrier for Long-Term Tumor Hypoxia Relief to Enhance Radiotherapy . ACS Nano 15:9, pages 15381-15394.
Crossref
Runqi Zhu, Tianqun Lang, Wenlu Yan, Xiao Zhu, Xin Huang, Qi Yin & Yaping Li. (2021) Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Advanced Science 8:10.
Crossref
Yan Shan Loo, Rajendran JC. Bose, Jason R. McCarthy, Intan Diana Mat Azmi & Thiagarajan Madheswaran. (2021) Biomimetic bacterial and viral-based nanovesicles for drug delivery, theranostics, and vaccine applications. Drug Discovery Today 26:4, pages 902-915.
Crossref
Marine Fidelle, Satoru Yonekura, Marion Picard, Alexandria Cogdill, Antoine Hollebecque, Maria Paula Roberti & Laurence Zitvogel. (2020) Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota. Frontiers in Immunology 11.
Crossref
B. Brett Finlay, Romina Goldszmid, Kenya Honda, Giorgio Trinchieri, Jennifer Wargo & Laurence Zitvogel. (2020) Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?. Nature Reviews Immunology 20:9, pages 522-528.
Crossref
Wujun Chen, Shuai Wang, Yudong Wu, Xin Shen, Zhu Guo, Qian Li & Dongming Xing. (2020) Immunogenic cell death: A link between gut microbiota and anticancer effects. Microbial Pathogenesis 141, pages 103983.
Crossref
Atieh Yaghoubi, Majid Khazaei, Amir Avan, Seyed Mahdi Hasanian & Saman Soleimanpour. (2020) The bacterial instrument as a promising therapy for colon cancer. International Journal of Colorectal Disease 35:4, pages 595-606.
Crossref
Han Shuwen, Yang Xi, Qi Quan, Pan Yuefen, Da Miao & Zhou Qing. (2019) Relationship between intestinal microorganisms and T lymphocytes in colorectal cancer. Future Oncology 15:14, pages 1655-1666.
Crossref
Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler & Walter Berger. (2018) Metal Drugs and the Anticancer Immune Response. Chemical Reviews 119:2, pages 1519-1624.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.